Mycobacteria dial down nucS to manage mutation risk

Antibiotic resistance in tuberculosis arises when bacteria acquire mutations that let them survive drug treatment. Many organisms use a mismatch repair system built from MutS and MutL proteins to correct DNA replication mistakes and keep mutation rates low. But important bacteria in the same group as the tuberculosis germ do not have MutS and MutL. Instead they rely on a different protein, NucS, that carries out a non-canonical mismatch repair (MMR) pathway. To learn how this alternative system is controlled, a team led by Esmeralda Cebrián-Sastre set out to map the genetic switches that turn the nucS gene on and off. Working in the safer laboratory species Mycobacterium smegmatis as a model, they defined the promoter region and the transcription start site of the nucS gene. That basic mapping was designed to reveal when and why a mycobacterial cell would make NucS protein, with the broader goal of understanding how changes in nucS expression might affect the appearance of adaptive mutations under stress, including antibiotic pressure.

The study established where transcription of nucS begins in Mycobacterium smegmatis and examined how much nucS is made at different points in growth. The researchers compared expression patterns in both Mycobacterium smegmatis and Mycobacterium tuberculosis and found a clear growth phase dependence: nucS expression drops sharply during the stationary phase when cells stop actively dividing. That decline mirrors what has been seen for canonical MMR components in other bacteria, consistent with the idea that expression of repair genes follows replication activity. The team also produced evidence that the alternative sigma factor σB may act as a negative regulator of nucS during the stationary phase, helping to reduce nucS levels when growth slows. In addition, they screened for environmental signals and identified candidate compounds that can modulate nucS expression, showing that nucS is responsive to external cues and could be transiently altered under stress.

These results matter because control of mismatch repair affects how quickly mutations accumulate and how rapidly antibiotic resistance can emerge. By showing that nucS is regulated in a growth-dependent way and by pointing to σB as a putative repressor, the work provides a concrete molecular link between stress, repair capacity, and mutation rates in mycobacteria. The discovery that non-canonical NucS-based repair and canonical MutS/MutL systems both not only perform similar DNA repair functions but also share similar regulatory logic is striking: it represents a case of double convergent evolution, where unrelated systems evolved the same job and similar ways to control it. The findings lay groundwork for further studies to probe the molecular mechanisms by which mycobacteria adjust genome integrity under stress and to explore whether manipulating nucS regulation could influence the emergence of drug resistance.